Emmanuelle A. P. Kumaran

Emmanuelle A. P. Kumaran

Auto-generated profile, based on publicly available information

Emmanuelle A. P. Kumaran

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2020 in BMC Medicine
Verified
Journal Article
Open access
PDF file
ABAnnie J. Browne
Annie J. Browne
BHBahar H. Kashef Hamadani
Bahar H. Kashef Hamadani
EKEmmanuelle A. P. Kumaran
Emmanuelle A. P. Kumaran
PRPuja Rao
Puja Rao
JLJoshua Longbottom
Joshua Longbottom
CDChristiane Dolecek
Christiane Dolecek
Background: Antimicrobial resistance (AMR) is an increasing threat to global health. There are > 14 million cases of enteric fever every year and > 135,000 deaths. The disease is primarily controlled by antimicrobial treatment, but this is becoming increasingly difficult due to AMR. Our objectives were to assess the prevalence and geographic distribution of AMR in Salmonella enterica serovars Typhi and Paratyphi A infections globally, to evaluate the extent of the problem, and to facilitate the creation of geospatial maps of AMR prevalence to help targeted public health intervention. Methods: We performed a systematic review of the literature by searching seven databases for studies published between 1990 and 2018. We recategorised isolates to allow the analysis of fluoroquinolone resistance trends over the study period. The prevalence of multidrug resistance (MDR) and fluoroquinolone non-susceptibility (FQNS) in individual studies was illustrated by forest plots, and a random effects meta-analysis was performed, stratified by Global Burden of Disease (GBD) region and 5-year time period. Heterogeneity was assessed using the I2 statistics. We present a descriptive analysis of ceftriaxone and azithromycin resistance. Findings: We identified 4557 articles, of which 384, comprising 124,347 isolates (94,616 S. Typhi and 29,731 S. Paratyphi A) met the pre-specified inclusion criteria. The majority (276/384; 72%) of studies were from South Asia; 40 (10%) articles were identified from Sub-Saharan Africa. With the exception of MDR S. Typhi in South Asia, which declined between 1990 and 2018, and MDR S. Paratyphi A, which remained at low levels, resistance trends worsened for all antimicrobials in all regions. We identified several data gaps in Africa and the Middle East. Incomplete reporting of antimicrobial susceptibility testing (AST) and lack of quality assurance were identified. Interpretation: Drug-resistant enteric fever is widespread in low- and middle-income countries, and the situation is worsening. It is essential that public health and clinical measures, which include improvements in water quality and sanitation, the deployment of S. Typhi vaccination, and an informed choice of treatment are implemented. However, there is no licenced vaccine for S. Paratyphi A. The standardised reporting of AST data and rollout of external quality control assessment are urgently needed to facilitate evidence-based policy and practice. Trial registration: PROSPERO CRD42018029432.

16 February 2018 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
EKEmmanuelle Kumaran
Emmanuelle Kumaran
Dyna DoumDyna Doum
Dyna Doum
VKVanney Keo
Vanney Keo
LSLy Sokha
Ly Sokha
BSBunLeng Sam
BunLeng Sam
JHJohn Hustedt
John Hustedt
Globally there are an estimated 390 million dengue infections per year, of which 96 million are clinically apparent. In Cambodia, estimates suggest as many as 185,850 cases annually. The World Health Organization global strategy for dengue prevention aims to reduce mortality rates by 50% and morbidity by 25% by 2020. The adoption of integrated vector management approach using community-based methods tailored to the local context is one of the recommended strategies to achieve these objectives. Understanding local knowledge, attitudes and practices is therefore essential to designing suitable strategies to fit each local context. A Knowledge, Attitudes and Practices survey in 600 randomly chosen households was administered in 30 villages in Kampong Cham which is one of the most populated provinces of Cambodia. KAP surveys were administered to a sub-sample of households where an entomology survey was conducted (1200 households), during which Aedes larval/pupae and adult female Aedes mosquito densities were recorded. Participants had high levels of knowledge regarding the transmission of dengue, Aedes breeding, and biting prevention methods; the majority of participants believed they were at risk and that dengue transmission is preventable. However, self-reported vector control practices did not match observed practices recorded in our surveys. No correlation was found between knowledge and observed practices either. An education campaign regarding dengue prevention in this setting with high knowledge levels is unlikely to have any significant effect on practices unless it is incorporated in a more comprehensive strategy for behavioural change, such a COMBI method, which includes behavioural models as well as communication and marketing theory and practice. ISRCTN85307778. The global incidence of dengue has grown dramatically over the last few decades and has become the most rapidly spreading mosquito-borne disease. To date, there is no specific treatment. A vaccine came on the market in 2015, but it will be several years before it becomes widely available and its efficacy is limited. Therefore vector control is the most important means of dengue prevention at the current time. The World Health Organization recommends the adoption of an integrated vector management approach using community-based methods tailored to the local context. In order to design appropriate strategies, it is essential to understand local knowledge, attitudes and practices regarding dengue vector control. We conducted a survey in the Cambodian province of Kampong Cham, to investigate the local knowledge levels as well as self-reported vector control practices and observed practices. We found a high knowledge of dengue transmission, and Aedes breeding and biting prevention methods. However, no correlation was found between self-reported vector control practices and observed practices. Additionally, knowledge levels did not correlate with actual vector control practices.

1 October 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MLMei Qiu Lim
Mei Qiu Lim
EKEmmanuelle A. P. Kumaran
Emmanuelle A. P. Kumaran
HTHwee Cheng Tan
Hwee Cheng Tan
DLDavid C. Lye
David C. Lye
YLYee Sin Leo
Yee Sin Leo
LRLaura Rivino
Laura Rivino
Zika virus (ZIKV), a flavivirus with homology to dengue virus (DENV), is spreading to areas of DENV hyper-endemicity. Heterologous T cell immunity, whereby virus-specific memory T cells are activated by variant peptides derived from a different virus, can lead to enhanced viral clearance or diminished protective immunity and altered immunopathology. In mice, CD8+ T cells specific for DENV provide in vivo protective efficacy against subsequent ZIKV infection. In humans, contrasting studies report complete absence or varying degrees of DENV/ZIKV T cell cross-reactivity. Moreover, the impact of cross-reactive T cell recognition on the anti-viral capacity of T cells remains unclear. Here, we show that DENV-specific memory T cells display robust cross-reactive recognition of ZIKV NS3 ex vivo and after in vitro expansion in respectively n = 7/10 and n = 9/9 dengue-immune individuals tested. In contrast, cross-reactivity toward ZIKV capsid is low or absent. Cross-reactive recognition of DENV or ZIKV NS3 peptides elicits similar production of the anti-viral effector mediators IFN-γ, TNF-α, and CD107a. We identify 9 DENV/ZIKV cross-reactive epitopes, 7 of which are CD4+ and 2 are CD8+ T cell epitopes. We also show that cross-reactive CD4+ and CD8+ T cells targeting novel NS3 epitopes display anti-viral effector potential toward ZIKV-infected cells, with CD8+ T cells mediating direct lyses of these cells. Our results demonstrate that DENV NS3-specific memory T cells display anti-viral effector capacity toward ZIKV, suggesting a potential beneficial effect in humans of pre-existing T cell immunity to DENV upon ZIKV infection.